Clinical Trial Update: rVA576 in Adult Mild to Moderate Bullous Pemphigoid Subjects [Phase 2]

View source ↗

Summary

Clinical trial update indicating completion of a Phase 2 study of rVA576 in adults with mild to moderate Bullous Pemphigoid.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bullous Pemphigoid

Drugs mentioned

• rVA576 (rVA576)

Snippet

Sponsor: AKARI Therapeutics | Conditions: Bullous Pemphigoid (BP) | Phase 2 | Status: COMPLETED